Grants Program

CurePSP has always believed that truly effective clinical interventions will follow good, solid basic scientific research. For this reason, CurePSP promotes research that helps generate an integrated picture of PSP, CBD and related tauopathies at pre-clinical and clinical levels. CurePSP believes that in the long term, research of this nature will prove indispensable in developing a prevention or cure for PSP, CBD and other tauopathies.

CurePSP has carefully structured its research program and has identified the programs that have been the most successful and those that need strengthening. With an increased research budget made possible through improved donor support, CurePSP will be able to markedly intensify the efforts to cure the disease in a way that promises relief for those afflicted today as well as hope for those who may be afflicted tomorrow.

Investigator-Initiated Research Projects

CurePSP accepts proposals for research projects from academic and non-academic institutions. There are no country-specific restrictions. All applicants must have a PhD or MD and hold at least a junior faculty or similar position. The CurePSPĀ Scientific Advisory Board peer-reviews all submissions and recommends the most appropriate projects for funding. Details surrounding the submission of grants are as follows:

  • Grant application deadlines areĀ March 15, July 15, and November 15
  • The maximum total grant amount awarded is $100,000 for up to 3 years in duration. However, greater or lesser amounts and durations may be offered depending on resources available.
  • You must use the application form for download below.
  • It is strongly recommended to contact Dr. Alex Klein, VP Scientific Affairs, prior to submission of an application.

Any investigators interested in submitting a grant application should first review CurePSP's Research Policies and Procedures.

For questions regarding the peer-review process, scientific aspects of the grant application, and grants administration or finances, please contact:

Alex Klein, PhD Vice President - Scientific Affairs